Blueprint Medicines Corp Quarterly Return On Equity in % from Q3 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Blueprint Medicines Corp quarterly/annual Return On Equity history and growth rate from Q3 2022 to Q2 2024.
  • Blueprint Medicines Corp Return On Equity for the quarter ending June 30, 2024 was -85.3 %, a 27.7% increase year-over-year.
  • Blueprint Medicines Corp annual Return On Equity for 2023 was -192 %, a 139% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -85.3 +32.6 +27.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -121 -20.4 -20.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -192 -111 -139% Oct 1, 2023 Dec 31, 2023
Q3 2023 -154 -65.2 -73.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -118 Apr 1, 2023 Jun 30, 2023
Q1 2023 -100 Jan 1, 2023 Mar 31, 2023
Q4 2022 -80.1 Oct 1, 2022 Dec 31, 2022
Q3 2022 -88.6 Jul 1, 2022 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.